← Back to search

EAGLE PHARMACEUTICALS, INC.

EGRX · NASDAQ

Pharmaceutical Preparation Manufacturing

Eagle Pharmaceuticals Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients' lives. Eagle's commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states.

ESG Scores

Overall ESG
2.9
Environmental
4.6
Social
2.5
Governance
6.2

Gender Diversity

Female Directors0.2857%
CEO GenderMale

Market Data

Price$0.35+0.00 (+0.00%)
Market Cap$5M
P/E Ratio0.38
EPS$—
52W High$3.87
52W Low$0.00
Beta0.27